GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (NAS:RGEN) » Definitions » Shiller PE Ratio
中文

Repligen (Repligen) Shiller PE Ratio

: 157.14 (As of Today)
View and export this data going back to 1986. Start your Free Trial

As of today (2024-04-24), Repligen's current share price is $171.28. Repligen's E10 for the quarter that ended in Dec. 2023 was $1.09. Repligen's Shiller PE Ratio for today is 157.14.

The historical rank and industry rank for Repligen's Shiller PE Ratio or its related term are showing as below:

RGEN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 50.73   Med: 149.23   Max: 538.77
Current: 157.14

During the past years, Repligen's highest Shiller PE Ratio was 538.77. The lowest was 50.73. And the median was 149.23.

RGEN's Shiller PE Ratio is ranked worse than
95.27% of 275 companies
in the Medical Devices & Instruments industry
Industry Median: 26.71 vs RGEN: 157.14

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Repligen's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.460. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.09 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Repligen Shiller PE Ratio Historical Data

The historical data trend for Repligen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 263.17 408.22 361.28 161.25 164.39

Repligen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.25 151.71 124.25 137.45 164.39

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Repligen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Repligen Shiller PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Repligen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Repligen's Shiller PE Ratio falls into.



Repligen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Repligen's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=171.28/1.09
=157.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Repligen's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Repligen's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.46/129.4194*129.4194
=-0.460

Current CPI (Dec. 2023) = 129.4194.

Repligen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.130 99.695 0.169
201406 0.090 100.560 0.116
201409 0.040 100.428 0.052
201412 -0.010 99.070 -0.013
201503 0.090 99.621 0.117
201506 0.110 100.684 0.141
201509 0.080 100.392 0.103
201512 0.010 99.792 0.013
201603 0.050 100.470 0.064
201606 0.110 101.688 0.140
201609 0.030 101.861 0.038
201612 0.150 101.863 0.191
201703 0.090 102.862 0.113
201706 0.240 103.349 0.301
201709 0.110 104.136 0.137
201712 0.270 104.011 0.336
201803 0.080 105.290 0.098
201806 0.060 106.317 0.073
201809 0.100 106.507 0.122
201812 0.120 105.998 0.147
201903 0.170 107.251 0.205
201906 0.170 108.070 0.204
201909 0.030 108.329 0.036
201912 0.070 108.420 0.084
202003 0.180 108.902 0.214
202006 0.300 108.767 0.357
202009 0.270 109.815 0.318
202012 0.360 109.897 0.424
202103 0.520 111.754 0.602
202106 0.640 114.631 0.723
202109 0.580 115.734 0.649
202112 0.500 117.630 0.550
202203 0.810 121.301 0.864
202206 0.880 125.017 0.911
202209 0.710 125.227 0.734
202212 0.850 125.222 0.878
202303 0.510 127.348 0.518
202306 0.350 128.729 0.352
202309 0.320 129.860 0.319
202312 -0.460 129.419 -0.460

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Repligen  (NAS:RGEN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Repligen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Repligen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Repligen (Repligen) Business Description

Traded in Other Exchanges
Address
41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Executives
Christine Gebski officer: See Remarks C/O REPLIGEN CORPORATION, 41 SYON ST. BLDG. 1, SUITE 100, WALTHAM MA 02453
Olivier Loeillot officer: President and CCO C/O REPLIGEN CORPORATION, 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02453
Jason K Garland officer: CFO 10000 WEHRLE DRIVE, CLARENCE NY 14031
Karen A Dawes director 579 BELLEVUE AVE, NEWPORT RI 02840
Martin D Madaus director 290 CONCORD ROAD, BILLERICA MA 01821
Jon Snodgres officer: CFO REPLIGEN CORPORATION, 41 SEYON STREET, BUILDING #1, SUITE 100, WALTHAM MA 02435
Anthony Hunt director, officer: Chief Executive Officer 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02452
Ralf Kuriyel officer: Senior VP, R&D 41 SEYON ST, BLDG 1, STE. 100, WALTHAM MA 02452
James Bylund officer: SVP, Global Operations & IT C/O REPLIGEN CORPORATION, 41 SYON ST. BLDG. SUITE 100, WALTHAM MA 02453
Konstantin Konstantinov director C/O CODIAK BIOSCIENCES, INC., 500 TECHNOLOGY SQUARE, 9TH FLOOR, CAMBRIDGE MA 02139
Manner Carrie Eglinton director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Ryan Thomas F Jr director
Nicolas Barthelemy director 1750 BELLA LAGUNA CT, ENCINITAS CA 92024
John Cox director C/O BIOVERATIV INC., 225 SECOND AVENUE, WALTHAM MA 02451
Rohin Mhatre director C/O REPLIGEN CORP., 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM MA 02453

Repligen (Repligen) Headlines

From GuruFocus

Repligen Appoints Martin D. Madaus to Board of Directors

By sperokesalga sperokesalga 02-09-2023

Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference

By Stock market mentor Stock market mentor 01-03-2023

Repligen to Report Second Quarter 2022 Financial Results

By PurpleRose PurpleRose 07-19-2022

Repligen Corporation to Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-24-2022

Repligen to Report First Quarter 2023 Financial Results

By sperokesalga sperokesalga 04-18-2023

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

By GuruFocusNews GuruFocusNews 06-25-2022

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

By GuruFocusNews GuruFocusNews 07-05-2022